Boji Pharmaceutical (300404.SZ) subsidiary Qingzhi Ointment obtained the notice of approval for drug clinical trials.

Zhixun Finance App News, Boji Pharmaceutical (300404.SZ) announced that recently, the company's wholly-owned subsidiary, Guangzhou Boji New Drug Clinical Research Center Co., Ltd., has obtained the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration for the "Qingzhi ointment".